NuGen Medical Devices Inc
NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, Vaccines, Veterinary, Home healthcare, and others. It also pro… Read more
NuGen Medical Devices Inc (NGMDF) - Total Assets
Latest total assets as of September 2025: $10.19 Million USD
Based on the latest financial reports, NuGen Medical Devices Inc (NGMDF) holds total assets worth $10.19 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
NuGen Medical Devices Inc - Total Assets Trend (2020–2024)
This chart illustrates how NuGen Medical Devices Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
NuGen Medical Devices Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
NuGen Medical Devices Inc's total assets of $10.19 Million consist of 60.5% current assets and 39.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 53.9% |
| Accounts Receivable | $99.96K | 0.8% |
| Inventory | $320.73K | 2.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $3.36 Million | 26.0% |
| Goodwill | $1.73 Million | 13.4% |
Asset Composition Trend (2020–2024)
This chart illustrates how NuGen Medical Devices Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NuGen Medical Devices Inc's current assets represent 60.5% of total assets in 2024, an increase from 44.4% in 2020.
- Cash Position: Cash and equivalents constituted 53.9% of total assets in 2024, up from 1.8% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 39.0% of total assets, a decrease from 54.0% in 2020.
- Asset Diversification: The largest asset category is intangible assets at 26.0% of total assets.
NuGen Medical Devices Inc Competitors by Total Assets
Key competitors of NuGen Medical Devices Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
NuGen Medical Devices Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - NuGen Medical Devices Inc generates 0.08x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - NuGen Medical Devices Inc is currently not profitable relative to its asset base.
NuGen Medical Devices Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.18 | 3.12 | 0.65 |
| Quick Ratio | 3.90 | 3.01 | 0.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.80 Million | $ 6.84 Million | $ -3.18 Million |
NuGen Medical Devices Inc - Advanced Valuation Insights
This section examines the relationship between NuGen Medical Devices Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 9.94 |
| Latest Market Cap to Assets Ratio | 0.44 |
| Asset Growth Rate (YoY) | 85.6% |
| Total Assets | $12.89 Million |
| Market Capitalization | $5.68 Million USD |
Valuation Analysis
Below Book Valuation: The market values NuGen Medical Devices Inc's assets below their book value (0.44 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: NuGen Medical Devices Inc's assets grew by 85.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for NuGen Medical Devices Inc (2020–2024)
The table below shows the annual total assets of NuGen Medical Devices Inc from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $12.89 Million | +85.65% |
| 2023-12-31 | $6.95 Million | +1.41% |
| 2022-12-31 | $6.85 Million | -22.56% |
| 2021-12-31 | $8.84 Million | -39.26% |
| 2020-12-31 | $14.56 Million | -- |